Results 171 to 180 of about 881,201 (350)

Clinical phenotyping of cardiogenic shock at a glance: A rapid, costless, streamlined approach

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiogenic shock (CS) is a heterogeneous syndrome in which recent guidelines have proposed clinical phenotyping based on the presence of hypoperfusion and/or congestion signs and symptoms. However, the impact of this clinical phenotype on outcomes remains poorly characterized.
Miloud Cherbi   +5 more
wiley   +1 more source

Criteria for Defining Stages of Cardiogenic Shock Severity.

open access: yesJournal of the American College of Cardiology, 2022
N. Kapur   +24 more
semanticscholar   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell   +8 more
wiley   +1 more source

Management of cardiogenic shock in older adults: A commentary on the 2024 American Heart Association Scientific Statement

open access: yesHeart Vessels and Transplantation
Cardiogenic shock occurring in older adults is associated with higher short-term mortality rates and poorer outcomes. However, current evidence and dedicated approaches in clinical practice to assess and manage this condition in older adults are limited.
Chieh-en Hsu   +2 more
doaj   +1 more source

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

open access: yesESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio   +12 more
wiley   +1 more source

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

open access: yesESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau   +12 more
wiley   +1 more source

The impact of a new ECMO program on clinical outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. [PDF]

open access: yes, 2013
Objective: To investigate if a new ECMO program will improve the outcome of patients who had acute myocardial infarction complicated with cardiogenic shock. Presented 24th Annual ELSO Conference. Philadelphia, PA.
Cavarocchi, MD, Nicholas C   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy